Simplifying to Speed up Time to Patient
“We’re thinking about a modular way of working, so if the technology develops very fast, we should be able to harness its potential quickly.”
What role can IT play in untangling increased trial complexity? Veeva’s Stephan Ohnmacht and Thomas Dieffenbronn (global head of strategy, insights, and technology for global clinical operations at Novartis) discuss how technology strategy in life sciences should strike a balance between quick fixes and innovation, and why simplicity holds the key to speeding up.
Contact the Veeva Business Consulting team to learn more about realizing the value of your technology investments.
